Microflow and multi-flow in vitro kits

Ended Purchase Order Awarded Last action

Contract number
75F40122P00364
Awardee
Awarding agency
Obligated
$16,959

Award facts

Contract value 100% obligated
$16,959.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325414 Biological Product (except Diagnostic) Manufacturing
PSC
6550 In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Rochester, NY 14623, USA

Award details come from SAM.gov/FPDS.

About this award

The Food and Drug Administration awarded a $16,959 firm fixed-price purchase order to Litron Laboratories LTD for microflow and multi-flow in vitro kits. The contract, executed on August 16, 2022, with a completion deadline of December 31, 2022, was performed at the contractor's facility in Rochester, New York. No set-aside designation was used, indicating the award resulted from open competition. Litron Laboratories, a Rochester-based biotechnology company specializing in genetic toxicology research tools and assays, has an established history of supporting the FDA's National Center for Toxicological Research through the delivery of specialized research kits focused on genotoxicity testing.

The microflow and multi-flow in vitro kits delivered under this contract support the FDA's toxicological research initiatives by providing advanced analytical tools for investigating genotoxic effects and chemical exposure impacts. These kits align with Litron Laboratories' core competency in developing non-animal models for toxicological research and represent part of the company's ongoing partnership with the FDA through multiple contract awards and research grants from the National Institute of Environmental Health Sciences focused on advancing genotoxicity testing methodologies.

Quick answers

Who was awarded contract 75F40122P00364?

75F40122P00364 was awarded to Litron Laboratories LTD by Food and Drug Administration (Department of Health and Human Services) on August 16, 2022.

How much is contract 75F40122P00364 worth?

The government has obligated $16,959 on 75F40122P00364.

Was contract 75F40122P00364 competed?

The extent of competition for 75F40122P00364 was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award